Advertisement
Brief Report| Volume 64, ISSUE 10, P907-911, November 15, 2008

Download started.

Ok

Elevated Neuroimmune Biomarkers in Sweat Patches and Plasma of Premenopausal Women with Major Depressive Disorder in Remission: The POWER Study

  • Giovanni Cizza
    Affiliations
    Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland
    Search for articles by this author
  • Andrea H. Marques
    Affiliations
    Section on Neuroendocrine Immunology and Behavior, Integrative Neural Immune Program, National Institute of Mental Health (NIMH), NIH, Rockville, Maryland
    Search for articles by this author
  • Farideh Eskandari
    Affiliations
    Section on Neuroendocrine Immunology and Behavior, Integrative Neural Immune Program, National Institute of Mental Health (NIMH), NIH, Rockville, Maryland

    Section on Neuroendocrine Immunology and Behavior, Integrative Neural Immune Program, NIMH, NIH and Virginia Mason Medical Center, Seattle, Washington
    Search for articles by this author
  • Israel C. Christie
    Affiliations
    Cardiovascular Behavioral Medicine Program, Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Sara Torvik
    Affiliations
    Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland
    Search for articles by this author
  • Marni N. Silverman
    Affiliations
    Section on Neuroendocrine Immunology and Behavior, Integrative Neural Immune Program, National Institute of Mental Health (NIMH), NIH, Rockville, Maryland

    Prince of Wales, National Center for Complementary and Alternative Medicine (NCCAM) Director's Fellow, NIH, Bethesda, Maryland
    Search for articles by this author
  • Terry M. Phillips
    Affiliations
    Nanoscale Immunodiagnostics Section, Laboratory of Bioengineering & Physical Science, National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH, Bethesda, Maryland
    Search for articles by this author
  • Esther M. Sternberg
    Correspondence
    Address reprint requests to Esther M. Sternberg, M.D., Director, Integrative Neural Immune Program, Section on Neuroendocrine Immunology & Behavior, NIMH/NIH, 5625 Fishers Lane (MSC-9401), Room 4N13, Rockville, MD 20852
    Affiliations
    Section on Neuroendocrine Immunology and Behavior, Integrative Neural Immune Program, National Institute of Mental Health (NIMH), NIH, Rockville, Maryland
    Search for articles by this author
  • POWER Study Group

      Background

      Major depressive disorder (MDD) is inconsistently associated with elevations in proinflammatory cytokines and neuropeptides. We used a skin sweat patch, recently validated in healthy control subjects, and recycling immunoaffinity chromatography to measure neuroimmune biomarkers in patients with MDD mostly in remission.

      Methods

      We collected blood at 8:00 am and applied skin sweat patches for 24 hours in 21- to 45-year-old premenopausal women (n = 19) with MDD (17/19 in remission) and age-matched healthy controls (n = 17) participating in the POWER (Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression) Study.

      Results

      Proinflammatory cytokines, neuropeptide Y, substance P, and calcitonin-gene-related peptide were significantly higher and vasoactive intestinal peptide, a marker of parasympathetic activity, was significantly lower in patients compared to controls, and depressive symptomatology strongly correlated with biomarker levels. All analytes were strongly correlated in the skin sweat patch and plasma in patients (r = .73 to .99; p < .0004).

      Conclusions

      The skin sweat patch allows detection of disrupted patterns of proinflammatory cytokines and neuropeptides in women with MDD in clinical remission, which could predispose to medical consequences such as cardiovascular disease, osteoporosis, and diabetes. This method permits measurement of cytokines in ambulatory settings where blood collection is not feasible.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Raison C.L.
        • Capuron L.
        • Miller A.H.
        Cytokines sing the blues: Inflammation and the pathogenesis of depression.
        Trends Immunol. 2006; 27: 24-31
        • Marques-Deak A.H.
        • Neto F.L.
        • Dominguez W.V.
        • Solis A.C.
        • Kurcgant D.
        • Sato F.
        • et al.
        Cytokine profiles in women with different subtypes of major depressive disorder.
        J Psychiatr Res. 2007; 41: 152-159
        • Marques-Deak A.
        • Cizza G.
        • Sternberg E.
        Brain-immune interactions and disease susceptibility.
        Mol Psychiatry. 2005; 10: 239-250
        • Hartman J.M.
        • Berger A.
        • Baker K.
        • Bolle J.
        • Handel D.
        • Mannes A.
        • et al.
        Quality of life and pain in premenopausal women with major depressive disorder: The POWER Study.
        Health Qual Life Outcomes. 2006; 4: 2
        • Eskandari F.
        • Martinez P.
        • Torvik S.
        • Phillips T.
        • Sternberg E.
        • Mistry S.
        • et al.
        Low bone mass in premenopausal women with depression.
        Arch Intern Med. 2007; 167: 2329-2336
        • Eskandari F.
        • Mistry S.
        • Martinez P.E.
        • Torvik S.
        • Kotila C.
        • Sebring N.
        • et al.
        Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: Implications for greater cardiovascular risk, The Power Study.
        Metabolism. 2005; 54: 918-924
        • Marques-Deak A.
        • Cizza G.
        • Eskandari F.
        • Torvik S.
        • Christie I.C.
        • Sternberg E.M.
        • et al.
        Measurement of cytokines in sweat patches and plasma in healthy women: Validation in a controlled study.
        J Immunol Methods. 2006; 315: 99-109
        • Phillips T.M.
        Multi-analyte analysis of biological fluids with a recycling immunoaffinity column array.
        J Biochem Biophys Methods. 2001; 49: 253-262
        • Phillips T.M.
        • Krum J.M.
        Recycling immunoaffinity chromatography for multiple analyte analysis in biological samples.
        J Chromatogr B Biomed Sci Appl. 1998; 715: 55-63
        • Sarno M.
        • Sarno L.
        • Baylink D.
        • Drinkwater B.
        • Farley S.
        • Kleerekoper M.
        • et al.
        Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease.
        Clin Chem Lab Med. 2001; 39: 223-228
        • Castle P.E.
        • Phillips T.M.
        • Hildesheim A.
        • Herrero R.
        • Bratti M.C.
        • Rodriguez A.C.
        Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
        Cancer Epidemiol Biomarkers Prev. 2003; 12: 1449-1456
        • Jones A.P.
        • Webb L.M.
        • Anderson A.O.
        • Leonard E.J.
        • Rot A.
        Normal human sweat contains interleukin-8.
        J Leukoc Biol. 1995; 57: 434-437
        • Sato K.
        • Sato F.
        Interleukin-1 alpha in human sweat is functionally active and derived from the eccrine sweat gland.
        Am J Physiol. 1994; 266: R950-R959
        • Thomas A.J.
        • Davis S.
        • Morris C.
        • Jackson E.
        • Harrison R.
        • O'Brien J.T.
        Increase in interleukin-1beta in late-life depression.
        Am J Psychiatry. 2005; 162: 175-177
        • Carney R.M.
        • Freedland K.E.
        Depression, mortality, and medical morbidity in patients with coronary heart disease.
        Biol Psychiatry. 2003; 54: 241-247
        • Silverman M.N.
        • Pearce B.D.
        • Biron C.A.
        • Miller A.H.
        Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.
        Viral Immunol. 2005; 18: 41-78
        • Gjerris A.
        • Rafaelsen O.J.
        • Vendsborg P.
        • Fahrenkrug J.
        • Rehfeld J.F.
        Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression.
        J Affect Disord. 1984; 7: 325-337
        • Hou C.
        • Jia F.
        • Liu Y.
        • Li L.
        CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
        Brain Res. 2006; 1095: 154-158
        • Kubera M.
        • Kenis G.
        • Bosmans E.
        • Kajta M.
        • Basta-Kaim A.
        • Scharpe S.
        • et al.
        Stimulatory effect of antidepressants on the production of IL-6.
        Int Immunopharmacol. 2004; 4: 185-192
        • Appenzeller B.M.
        • Schummer C.
        • Rodrigues S.B.
        • Wennig R.
        Determination of the volume of sweat accumulated in a sweat-patch using sodium and potassium as internal reference.
        J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 852: 333-337